1213234-82-2

Basic information

• Product Name: 3,4,5-tribromobenzyl azide
• Synonyms: 3,4,5-tribromobenzyl azide
• CAS NO: 1213234-82-2
• Molecular Weight: 369.841
• Mol File: 1213234-82-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3,4,5-tribromobenzyl azide(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4,5-tribromobenzyl azide(1213234-82-2)
• EPA Substance Registry System: 3,4,5-tribromobenzyl azide(1213234-82-2)

Safety Data

• Hazardous Substances Data: 1213234-82-2(Hazardous Substances Data)

Upstream product

• 100-11-8 1-bromomethyl-4-nitro-benzene 
• 63516-03-0 α-bromo-p-toluidine 
• 73557-59-2 1-methyl-3,4,5-tribromobenzene 
• 106-49-0 p-toluidine 
• 81278-48-0 1-(bromomethyl)-3,4,5-tribromobenzene 

Downstream Products

• 1220449-30-8 ethyl 2-[1-(3,4,5-tribromobenzyl)-1H-1,2,3-triazol-4-yl]-1,3-benzothiazole-6-carboxylate 
• 1220449-18-2 ethyl {6-[1-(3,4,5-tribromobenzyl)-1H-1,2,3-triazol-4-yl][1,3]thiazolo[4,5-b]pyrazin-2-yl}carbamate 
• 1213234-98-0 5-[1-(3,4,5-tribromobenzyl)-1H-1,2,3-triazol-4-yl]nicotinonitrile 
• 1346428-26-9 C₁₄H₇Br₃N₆ 
• 1346427-32-4 C₁₀H₇Br₃N₄O 
• 1346427-52-8 C₁₀H₅Br₃N₄ 
• 1346427-59-5 C₁₂H₈Br₃N₇O₂ 
• 1346427-67-5 C₁₀H₈Br₃N₅O 
• 1346427-70-0 C₁₅H₁₂Br₃N₅O₃ 
• 1346427-73-3 C₁₆H₁₄Br₃N₅O₃ 
• 1346427-75-5 C₁₇H₁₆Br₃N₅O₃ 
• 1346427-77-7 C₁₈H₁₈Br₃N₅O₃ 
• 1213234-73-1 (5-{5-[1-(3,4,5-Tribromobenzyl)-1H-1,2,3-triazol-4-yl]pyridin-3-yl}-2H-tetrazol-2-yl)acetic acid 
• 1213234-99-1 C₁₅H₉Br₃N₈ 

Relevant articles and documents

Conversion of systemically-distributed triazole-based stearoyl-CoA desaturase (SCD) uHTS hits into liver-targeted SCD inhibitors

It has been demonstrated that once-a-day dosing of systemically-distributed SCD inhibitors leads to adverse events in eye and skin. Herein, we describe our efforts to convert a novel class of systemically-distributed potent triazole-based uHTS hits into liver-targeted SCD inhibitors as a means to circumvent chronic toxicity.

HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE

Heteroaromatic compounds of structural formula (I) are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD). The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and met